Biologics Outsourcing Global Market 2017 - Forecast to 2025 - Research and Markets

DUBLIN--()--The "Biologics Outsourcing Global Market - Forecast to 2025" report has been added to Research and Markets' offering.

The biologics outsourcing global market is expected to grow at double digit CAGR to reach $70.3 billion by 2025

The biologics outsourcing global market is estimated region wise with various drug discovery, development and manufacturing segments and their market shares. This section also included the market sizing of antibodies, recombinant proteins, vaccines, and others which included gene therapy, cell therapy. The emerging trends and strategies adopted by global biopharmaceutical companies and their impact on outsourcing market were discussed. A list of approved drugs (2012-2016) along with phase wise pipeline analysis for biologics was included.

Although biologics are much costlier than small molecule drugs, these classes of drugs prove to be highly beneficial for the patient and also bring about 40% higher profit to the manufacturers when compared to small molecule drug treatments. Due to the increasing demand for biologics drugs and increased regulatory approvals for these drugs, there is huge demand for biologics manufacture and testing at various levels of clinical studies as well as commercial supply.

The Large Biopharma companies are coming up with strategies to cut down on their operational costs and concentrate more on their core competencies by outsourcing this piece of work to contract research organizations (CROs), contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs). These organizations bridge the gap between demand and supply and ensure the drug discovery process gets much faster and convenient thus bringing life saving drugs to the market to reach the needy patients.

Key Topics Covered:

1 Biologics Outsourcing Global Market

Landscape of Biologics Market

Biologics Global Market

China Biologics Outsourcing Market

China Vs India - Biologics Market

2 Market Analysis

3 Biologics Outsourcing Global Market, Market Analysis

  • Discovery and Pre-Clinical Development Process
  • Biologics Outsourcing Global Market, by Product Type
  • Market Share Analysis
  • Company Developments
  • Service Cost Analysis

4 Biologics Outsourcing Global Market - Animal Model Services

  • Ethics and Regulations
  • Alternatives to Animal Models
  • Overview of Applications of Animal Models
  • Market Share Analysis
  • Competitive Landscape
  • Company Developments

5 Biologics Outsouring Global Market - Biomanufacturing

  • Contract Biomanufacturing, by Process
  • Contract Biomanufacturing Global Market, by End Users
  • Contract Biomanufacturing Global Market, by Region
  • Competitive Landscape
  • Company Developments

6 Biologics Outsourcing Global Market - Cell Line Development

  • Cell Line Development
  • Host Cell Lines
  • Cell Line Development Services Market, by Expression System
  • Cell Line Development Services, by Cell Type
  • Cell Line Development Services, by Applications
  • Key Developments
  • Market Share Analysis

7 Company Profiles

  • Abzena Plc
  • Adimab Llc.
  • Albany Molecular Research Inc
  • Beijing Vital Star Biotechnology Co. Ltd.
  • Boehringer Ingelheim
  • Catalent Inc.
  • Charles River Laboratories
  • Crown Biosciences
  • Genoway
  • Genscript Biotech Corporation
  • Gl Biochem
  • Horizon Discovery Group, Plc
  • Jackson Laboratory
  • Innovent Biologics
  • Jhl Biotech Inc.
  • Joinn Laboratories Co. Ltd
  • Lonza Group
  • Merck Kgaa
  • Patheon N.V.
  • Pharmalegacy Biotechnology
  • Pharmaron
  • Prosci Inc.
  • Proteogenix
  • Psychogenics Inc
  • Selexis Sa
  • Shanghai Medicilon
  • Shangpharma Corporation /Shanghai Chempartner
  • Sino Biological
  • Sundia Meditech Co., Ltd.
  • Syngene International
  • Taconic Biosciences
  • Viva Biotech Ltd.
  • Wuxi Apptec

For more information about this report visit https://www.researchandmarkets.com/research/ptmlxb/biologics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals , Pharmaceutical Manufacturing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biopharmaceuticals , Pharmaceutical Manufacturing